Company Search:
Advanced Search
Sponsored Links
Clal Biotechnology Industries Limited Company Snapshot
Clal Biotechnology Industries Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clal Biotechnology Industries Limited with three other miscellaneous service companies in Middle East: Kadimastem Ltd (2015 sales of 1.03 million Israel Shekels [US$282,885.04 ] ), Redhill Biopharma Ltd (11,658.18 Israel Shekels [US$3,208.10 ] ), and Evogene Limited (43.25 million Israel Shekels [US$11.90 million] of which 100% was Agricultural Crops).

Sales Analysis. Clal Biotechnology Industries Limited reported sales of 31.77 million Israel Shekels (US$8.74 million) for the year ending December of 2015. This represents a sharp decrease of 47.6% versus 2014, when the company's sales were 60.63 million Israel Shekels. Contributing to the drop in overall sales was the 54.1% decline in Medivned, from 17.26 million Israel Shekels to 7.91 million Israel Shekels. There were also decreases in sales in Kayortech (down 43.3% to 22.70 million Israel Shekels) . However, these declines were partially offset by the increase in sales of Other (up 178.3% to 29.77 million Israel Shekels) and Gmida Sal (up 48.0% to 18.62 million Israel Shekels) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Clal Biotechnology Industries Limited
  Stock Performance Chart for Clal Biotechnology Industries Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2017): 3.13
(Figures in Israel Shekels)
1 Week -2.0%   13 Weeks -3.1%  
4 Weeks 22.1%   52 Weeks -3.9%  
Clal Biotechnology Industries Limited Key Data:
  Ticker: CBI Country: Israel
  Exchanges: TEL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 31,765,000
(Year Ending Jan 2016).
Employees: 145
  Currency: Israel Shekels Market Cap: 426,697,140
  Fiscal Yr Ends: December Shares Outstanding: 136,150,970
  Share Type: Ordinary Closely Held Shares: 94,964,996
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.